The NIH has awarded WashU Medicine an $11.7 million grant to study how inflammation drives myeloproliferative neoplasms, a group of blood cancers at high risk of progressing to acute myeloid leukemia.
“This funding supports a true team-science effort because all four projects look at inflammation, but each in a different way,” said principal investigator Stephen T. Oh, MD, PhD, the Samuel B. Grant Professor of Clinical Medicine and co-director of WashU Medicine’s Division of Hematology. “Together, they will give us a more complete picture of how MPNs behave. If we understand the biology of the diseases more deeply, we can lay the groundwork for translating basic research into improved therapeutics that may one day change the course of these diseases.”